FindTrial
Sign In

Evaluation of different complete blood count(CBC) parameters in prognosis of COVID -19 patients

Evaluation of Hematological parameters as prognostic indicators in COVID -19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030789
Enrollment
100
Registered
2021-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

KIMS Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)ALL RT-PCR POSITIVE COVID-19 PATIENTS

Exclusion criteria

Exclusion criteria: 1)All COVID unrelated cases . 2)Patients in which proper clinical details missing

Design outcomes

Primary

MeasureTime frame
These parameters are expected to act as indicators of immune status of patient, hyperinflammatory and cytokine storm status, indicators of superinfection , disease severity and extent of systemic inflammationTimepoint: The parameters will be assessed at the time of admission and at the time of discharge in case of general ward patients and at 1 week interval in case of ICU patients—

Secondary

MeasureTime frame
FEW DERIVED HEMATOLOGICAL PARAMETERS CAN ACT AS INDICTORS OF POOR PROGNOSIS IN COVID 19 PATIENTSTimepoint: Parameters will be assessed at the time of discharge in general ward patients and at 1 week interval in ICU patients—

Countries

India

Contacts

Public ContactSarojini Raman

Kalinga Institute of Medical Sciences,Bhubaneswar

sarojini.raman@kims.ac.in7077288117

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026